Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 USD | +3.26% | -1.99% | +146.67% |
22/03 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
21/03 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
Sales 2024 * | 4.5M 375M | Sales 2025 * | 500K 41.71M | Capitalization | 261M 21.81B |
---|---|---|---|---|---|
Net income 2024 * | -43M -3.59B | Net income 2025 * | -75M -6.26B | EV / Sales 2024 * | 58.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 523 x |
P/E ratio 2024 * |
-5.82
x | P/E ratio 2025 * |
-3.48
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.51% |
1 day | +3.26% | ||
1 week | -1.99% | ||
Current month | +4.23% | ||
1 month | +4.23% | ||
3 months | +6.73% | ||
6 months | +182.80% | ||
Current year | +146.67% |
Managers | Title | Age | Since |
---|---|---|---|
Lara Sullivan
CEO | Chief Executive Officer | 51 | 11/19/11 |
Pamela Connealy
DFI | Director of Finance/CFO | 63 | 01/21/01 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Flavin
FOU | Founder | 55 | 11/18/11 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 01/21/01 |
Darren Cline
BRD | Director/Board Member | 59 | 01/21/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 4.44 | +3.26% | 478,257 |
26/24/26 | 4.3 | 0.00% | 164,540 |
25/24/25 | 4.3 | -3.37% | 520,281 |
24/24/24 | 4.45 | -1.11% | 233,615 |
23/24/23 | 4.5 | -0.66% | 384,174 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.67% | 253M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- PYXS Stock